What's Happening?
Alliance Health, North Carolina's public managed care organization for Medicaid, has partnered with Cortica to provide autism treatment in the Raleigh and Charlotte areas. This collaboration aims to curb the rapidly increasing costs of Applied Behavior
Analysis (ABA) therapy, which has seen a 347% rise in spending from $121.7 million in fiscal 2022 to $544.4 million in fiscal 2025. The number of beneficiaries receiving ABA therapy also increased significantly, from 3,844 to 13,447. Alliance Health's CEO, Rob Robinson, stated that the organization is committed to innovative approaches to services and is not solely relying on fraud, waste, and abuse prevention to address spending concerns. Cortica's model integrates ABA therapy within physician-led medical care, offering a more comprehensive approach that includes medical care, developmental therapies, and family support. This move comes amidst increased scrutiny of ABA therapy costs and practices, with a March state forecast projecting annual spending to exceed $1 billion in fiscal 2027.
Why It's Important?
This partnership is significant for North Carolina's healthcare landscape, particularly for families with children on the autism spectrum who rely on Medicaid for therapy. The soaring costs of ABA therapy have put a strain on the state's Medicaid budget, prompting a need for more sustainable and effective care models. Cortica's physician-led, integrated approach to autism treatment could set a new standard for care delivery, potentially improving outcomes by addressing the child's needs holistically rather than focusing solely on ABA hours. This initiative also reflects a broader trend in healthcare towards value-based care, where payment is tied to outcomes rather than the volume of services. If successful, this model could be replicated in other states facing similar challenges with rising healthcare costs and the need for quality improvement in specialized therapies. The involvement of a public managed care organization like Alliance Health in pioneering such a model underscores the potential for public-private partnerships to drive innovation and efficiency in healthcare.
What's Next?
The effectiveness of the Alliance Health-Cortica partnership will be closely monitored, with key metrics including access to care, patient outcomes, and total cost. While the financial terms of the deal have not been disclosed, the success of this model could influence future Medicaid contracts and potentially lead to wider adoption of integrated care approaches for autism treatment. State lawmakers and health departments are also implementing new regulations to address the rising costs and ensure quality of ABA therapy. These include requirements for closed networks for behavioral health treatment and revised authorization periods for therapy hours. House Bill 34, which aims to tighten Medicaid provider screening and program-integrity controls, is also progressing through the legislature. These ongoing efforts indicate a sustained focus on reforming autism therapy provision in North Carolina, with potential implications for providers and beneficiaries across the state.
Beyond the Headlines
The partnership between Alliance Health and Cortica highlights a critical ethical and economic dilemma in healthcare: balancing access to necessary therapies with fiscal responsibility. The rapid escalation of ABA therapy costs, coupled with concerns about potential over-prescription and quality of care, underscores the need for innovative solutions. Cortica's model, which emphasizes physician-led care and integrates various therapeutic components, challenges the traditional volume-based approach to ABA. This shift could lead to a re-evaluation of how autism services are delivered and funded, potentially fostering a more patient-centered and outcome-driven system. The broader implications extend to the role of managed care organizations in driving healthcare reform and the potential for value-based contracts to incentivize better patient outcomes. This development could also spark discussions about the standardization of quality measures for ABA therapy and the need for robust oversight to prevent fraud and ensure that taxpayer dollars are stewarded responsibly.
